Quadrature Capital’s Satellos Bioscience MSLE Stock Holding History
Bought
Maintained
Sold
Other funds holding MSLE
SL
SVCM
6CM
Quadrature Capital's MSLE Position: Q3 2026 in Review
Quadrature Capital opened a new position in Satellos Bioscience (MSLE) in Q3 2026: 38,916 shares worth $331K. The stake represents ﹤0.01% of the portfolio and ranks #1570 among its holdings.
30 funds tracked by Wall St. Rank hold MSLE as of Q3 2026.
- Quadrature Capital held 38,916 shares of Satellos Bioscience worth $331K as of Q3 2026.
- Satellos Bioscience was a new Quadrature Capital position in Q3 2026.
- Satellos Bioscience made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1570 holding.
- 30 funds tracked by Wall St. Rank held Satellos Bioscience as of Q3 2026.
Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.